CHINA BIOLOGIC PRODUCTS HLD. overview

China Biologic Reports Financial Results for the First Quarter of 2019 PR Newswire BEIJING, May 10, 2019 --1Q19 Total Sales Up 15.4% YoY in USD terms, or 22.3% YoY in RMB terms; Net Income Up 19.3% YoY to $37.7 Million ; Non-GAAP Adjusted Net Income Up 14.3% YoY in RMB terms -- BEIJING , May 10, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced...

China Biologic Products to Report First Quarter 2019 Financial Results PR Newswire BEIJING, April 30, 2019 BEIJING , April 30, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced that the Company plans to release its first quarter 2019 financial results on Friday, May 10, 2019 after the market closes. The Company's management will hold a...

China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2018 PR Newswire BEIJING, March 6, 2019 -- 4Q18 Total Sales Up 27.5% YoY in USD terms, or 33.5% YoY in RMB terms; Net Income Up $59.4 Million YoY to $34.8 Million ; Non-GAAP Adjusted Net Income Up 23.9% YoY in RMB terms -- -- FY18 Total Sales Up 26.1% YoY in USD terms, or 23.5% YoY in RMB terms; Net Income Up 88.7% YoY to $128.1 Million ; Non-GAAP Adjusted Net Income Up 0.6% YoY in RMB terms -- -- Issues Forecast for...

China Biologic Products to Report Fourth Quarter and Fiscal Year 2018 Financial Results PR Newswire BEIJING, Feb. 25, 2019 BEIJING , Feb. 25, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced that the Company plans to release its fourth quarter and fiscal year 2018 financial results on Wednesday, March 6, 2019 after the market closes. The...

China Biologic Reiterates Full Year 2018 Financial Forecast PR Newswire BEIJING, Jan. 7, 2019 BEIJING , Jan. 7, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO ) ( "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today reiterated its previously revised full year 2018 forecast. Full year 2018 non-GAAP adjusted income from operations is expected to increase in the range of 0% to 2% in RMB terms and non-GAAP...

China Biologic Announces Dismissal of Lawsuit Filed in Cayman Islands by Former Chairman PR Newswire BEIJING, Dec. 14, 2018 BEIJING , Dec. 14, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO ) (" China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced that the Grand Court of the Cayman Islands (the "Court") dismissed the lawsuit previously filed against the Company by Mr. David (Xiaoying) Gao , the...